AstraZeneca Looks To Muscle In On BMS-Dominated Neoadjuvant NSCLC Setting

 
• By Alaric DeArment
  
AstraZeneca announced Phase III results from the AEGEAN trial of Imfinzi in neoadjuvant NSCLC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D